Compare QIPT & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QIPT | ANIK |
|---|---|---|
| Founded | 1993 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.2M | 134.8M |
| IPO Year | N/A | 1993 |
| Metric | QIPT | ANIK |
|---|---|---|
| Price | $3.58 | $9.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | $3.83 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 566.3K | 127.1K |
| Earning Date | 02-11-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $245,359,000.00 | $112,806,000.00 |
| Revenue This Year | $28.30 | N/A |
| Revenue Next Year | $1.79 | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.55 |
| 52 Week Low | $1.35 | $7.87 |
| 52 Week High | $3.61 | $18.37 |
| Indicator | QIPT | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | 74.01 | 38.47 |
| Support Level | $3.52 | $9.16 |
| Resistance Level | $3.54 | $9.60 |
| Average True Range (ATR) | 0.03 | 0.24 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 41.67 | 15.75 |
Quipt Home Medical Corp is a provider of durable medical equipment (DME) and home medical equipment (HME) in the United States. The Company specializes in delivering in-home treatments for the management of chronic conditions, with a primary focus on respiratory diseases, and supports patients with heart and pulmonary diseases, sleep apnea, reduced mobility, and other chronic health challenges. Its products and services include Sleep Apnea and PAP treatment, home medical equipment, home ventilation, and custom mobility solutions. The Company operates in a single business segment, comprising the sale and rental of medical equipment and related devices, and serves patients across 27 states in the United States.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.